How it Works

Vincristine is a chemotherapy drug in a class of medications known as vinca alkaloids. It is commonly used to treat various types of cancer, including leukemia, lymphoma, myleoma, and solid tumors. Vincristine works by disrupting the cell division process, specifically during mitosis (cell division), and preventing the formation of the mitotic spindle, which is essential for separating chromosomes and ensuring that each daughter cell receives the correct number of chromosomes.

How it’s Administered

Vincristine is typically administered by healthcare professionals, such as doctors or nurses, in a clinical setting like a hospital or outpatient clinic. It is not typically taken orally in the form of a pill because it can cause severe irritation and damage to the digestive tract. Instead, Vincristine is administered through intravenous (IV) infusion or injection.

Who Shouldn’t Take Isatuximab

Vincristine is based on several factors, including the type and stage of cancer, the patient's overall health, and the specific treatment plan. Here are some general guidelines for who may receive Vincristine:

• Cancer Patients

• Pediatric Patients 

• Adult Patients

• Central Nervous System (CNS) Cancers

What are the side effects?

Vincristine, like many chemotherapy drugs, can cause various side effects. The severity and specific side effects experienced by a person can vary based on factors such as the dose, the individual's overall health, and the type of cancer being treated. Common side effects of Vincristine include:

1. Nausea and Vomiting: Nausea and vomiting are common side effects of chemotherapy, including Vincristine. Medications called antiemetics are often prescribed to help manage these symptoms.

2. Peripheral Neuropathy: This is one of the most distinctive side effects of Vincristine. It can cause damage to the nerves in the extremities (hands and feet). Symptoms may include numbness, tingling, weakness, and difficulty with fine motor skills. Peripheral neuropathy can be temporary or, in some cases, may persist after treatment.

3. Constipation: Vincristine can slow down bowel movements, leading to constipation. Adequate hydration, dietary changes, and medications can help manage this side effect.

4. Hair Loss: Some people receiving Vincristine may experience hair thinning or hair loss. This is usually temporary, and hair often starts to grow back after treatment ends.

5. Fatigue: Chemotherapy can lead to fatigue, which can be quite pronounced. Rest and pacing daily activities can help manage this symptom.

6. Muscle Weakness: Weakness in the muscles can occur, particularly in the legs, and it may affect coordination and mobility.

7. Jaw Pain or Jaw Tightness: Some individuals may experience jaw pain or tightness, which can be due to the effect of Vincristine on the muscles.

8. Bone Pain: Bone pain and muscle cramps can occur as a side effect of Vincristine. This pain is usually temporary.

9. Low Blood Cell Counts: Vincristine can temporarily reduce the production of blood cells in the bone marrow, leading to decreased levels of white blood cells (increased risk of infection), red blood cells (anemia), and platelets (increased risk of bleeding).

10. Allergic Reactions: Although rare, allergic reactions to Vincristine can occur. Signs of an allergic reaction may include rash, itching, swelling, dizziness, and difficulty breathing.

11. Gastrointestinal Issues: In addition to constipation, Vincristine can cause other gastrointestinal issues such as diarrhea, abdominal pain, and mouth sores.

Commonly Used With 

In the treatment of leukemia, vincristine is often used in combination with other chemotherapy drugs as part of a multi-agent chemotherapy regimen. The specific combination of drugs used can vary depending on the type of leukemia (acute lymphoblastic leukemia [ALL] or acute myeloid leukemia [AML]), the patient's age and overall health, and the risk profile of the disease. Here are some examples of drugs that may be commonly used in combination with vincristine for leukemia treatment:

• For Acute Lymphoblastic Leukemia (ALL):

  • Methotrexate: Methotrexate is frequently used in combination with vincristine in the treatment of ALL. It is an antimetabolite drug that interferes with the growth of cancer cells.

  • Cytarabine (Ara-C): Cytarabine is another chemotherapy drug used in combination with vincristine for ALL. It acts by inhibiting DNA synthesis in cancer cells.

  • Prednisone: Prednisone is a corticosteroid that is often included in ALL treatment regimens. It helps to reduce inflammation and suppress the immune response.

  • L-asparaginase: L-asparaginase is an enzyme used in some ALL treatment protocols. It deprives leukemia cells of an essential nutrient, asparagine, which they need to grow.

• For Acute Myeloid Leukemia (AML):

  • Cytarabine (Ara-C): Cytarabine is a key chemotherapy drug used in the treatment of AML. It is often combined with other drugs, including vincristine, in different AML treatment regimens.

  • Daunorubicin or Idarubicin: These anthracycline drugs are commonly used alongside cytarabine and may be used in AML induction therapy.

  • Mitoxantrone: Mitoxantrone is another anthracycline drug used in certain AML treatment regimens.

Learn more about your treatments in Cure Hub